PMID: 8951675Jan 1, 1996Paper

The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent

Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
J M YanniD A Gamache

Abstract

Olopatadine (AL-4943A; KW-4679) [(z)-11-[3-(dimethylamino)propylidene]-6, 11-dihydrodibenz[b,e]oxepine-2 acetic acid hydrochloride] is an anti-allergic agent which inhibits mast cell mediator release and possesses histamine H1 receptor antagonist activity. Studies were conducted to characterize the in vitro and in vivo pharmacological profile of this drug relevant to its topical ocular use. AL-4943A inhibits histamine release in a concentration-dependent fashion (IC50 = 559 microM) from human conjunctival mast cell preparations in vitro. Histamine release was not stimulated by AL-4943A at concentrations as high as 10 mM. In contrast, ketotifen stimulated histamine release at concentrations slightly higher than effective inhibitory concentrations. AL-4943A did not display any in vitro cyclooxygenase or 5-lipoxygenase inhibition. Topical ocular application of AL-4943A effectively inhibits antigen- and histamine-stimulated conjunctivitis in guinea pigs. Passive anaphylaxis in guinea pig conjunctiva was attenuated by AL-4943A applied 30 min prior to intravenous or topical ocular antigen challenge (ED50 values 0.0067% and 0.0170%, w/v, respectively). Antihistaminic activity in vivo was demonstrated using a model of histamine-induced...Continue Reading

References

Jul 15, 1979·Analytical Biochemistry·H W CookW E Lands
Jan 1, 1991·Journal of Ocular Pharmacology·G J BerdyR L Giovanoni
Jul 1, 1990·The Journal of Allergy and Clinical Immunology·A M IraniL B Schwartz
Aug 1, 1985·The Journal of Allergy and Clinical Immunology·H R KatzK F Austen
Mar 1, 1989·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·A M Irani, L B Schwartz
Jul 1, 1981·Agents and Actions·D M RitchieM E Rosenthale
Aug 1, 1980·American Journal of Ophthalmology·M B AbelsonM H Friedlaender
Jan 1, 1993·International Archives of Allergy and Immunology·J M YanniJ M Spellman
May 1, 1962·The Journal of Experimental Medicine·B BENACERRAF, B B LEVINE

❮ Previous
Next ❯

Citations

Jun 4, 2004·Current Allergy and Asthma Reports·Leonard BieloryStephen Bigelson
Jul 11, 2006·Current Allergy and Asthma Reports·Mark B Abelson, David Granet
Nov 27, 2007·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Piyush PatelG Michael Wall
Nov 26, 2009·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Michael A Kaliner
Jan 13, 2006·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Eli O MeltzerJ Rod Barnes
May 7, 2005·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Ellen B CookFrank M Graziano
Nov 30, 2005·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Paul H RatnerLewis H Silver
Jun 29, 2001·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·B Q LanierE F Juniper
May 25, 2002·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Duraisamy KempurajTheoharis C Theoharides
Oct 6, 1998·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·M B Abelson
Jan 20, 1998·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·J M YanniN A Sharif
Mar 22, 2003·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·C Schoch
Aug 25, 2005·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Hannele HasalaHannu Kankaanranta
Sep 7, 2007·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Clay BeauregardJohn Yanni
May 15, 2013·The World Allergy Organization Journal·Daniel C WilliamsPeter K Smith
May 1, 2006·Expert Review of Clinical Immunology·Steven J Lichtenstein, Mark B Abelson
Apr 25, 2008·Expert Opinion on Drug Metabolism & Toxicology·Mark B Abelson, Paul J Gomes
Oct 29, 2011·Expert Opinion on Drug Metabolism & Toxicology·Andrew S NickelsRaoul Wolf
Aug 9, 2005·Expert Opinion on Emerging Drugs·Andrea Leonardi
Mar 24, 2010·Expert Opinion on Pharmacotherapy·Andrea Leonardi, Luigi Quintieri
Aug 25, 2004·Current Medical Research and Opinion·Bobby Q LanierGreg L Ledgerwood
Feb 20, 2008·Immunology and Allergy Clinics of North America·Leonard Bielory
Apr 2, 2008·Experimental Eye Research·M Eugenia Sanchis-MerinoSilvia Pastor
Jul 5, 2005·Expert Opinion on Investigational Drugs·M Hingorani
Jul 2, 2015·European Journal of Pharmacology·Tao ZhangJohn Jarlath Walsh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anaphylaxis

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.